Page last updated: 2024-11-06

1,2,4-trimethylcyclohexane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,2,4-trimethylcyclohexane: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID91517
MeSH IDM0189046

Synonyms (27)

Synonym
cyclohexane, 1,2,4-trimethyl-, (1alpha,2beta,4beta)-
cyclohexane, 1,2,4-trimethyl-, (1r,2r,4r)-rel-
nsc 73967
1,2,4-trimethylcyclohexane
cyclohexane, 1,2,4-trimethyl-
1,4-trimethylcyclohexane
cyclohexane,2,4-trimethyl-
2234-75-5
nsc-18907
nsc18907
T0825
LMFA11000635
einecs 218-783-4
nsc 18907
ai3-18880
FT-0634154
AKOS015903384
(1r,2r,4r)-1,2,4-trimethyl-cyclohexane
J-500297
VCJPCEVERINRSG-UHFFFAOYSA-N
mfcd00019385
1,2,4-trimethyl cyclohexane
FT-0773851
DTXSID60862883
3-[2-(3-chloro-phenyl)-ethyl]-pyridine-2-carboxylicacidtert-butylamide
CS-0450064
CAA23475
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (37.50)18.2507
2000's3 (37.50)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.12

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.12 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index42.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.12)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]